Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) P/B ratio

As of 25 September 2026, Elevance Health, Inc. (ELV) trades at a P/B ratio of 1.9×. Over the past ten years it has ranged from 1.2× (November 2016) to 3.6× (October 2022); the current reading is higher than 31% of that period. That is below the Healthcare Plans industry median of 2.5× and below the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 1.8× (13.56%)
FY2024 2.1× (28.02%)
FY2023 2.9× (13.60%)
FY2022 3.3× 6.06%
FY2021 3.1× 28.96%
FY2020 2.4× (0.27%)
FY2019 2.4× 2.41%
FY2018 2.4× 6.51%
FY2017 2.2× 48.63%
FY2016 1.5× (5.72%)

Quarterly

Period P/B ratio Change
Jun 2026 1.9× 27.58%
Mar 2026 1.5× (18.09%)
Dec 2025 1.8× 8.97%
Sep 2025 1.6× (18.06%)
42 more quarters

Against its own ten years

Low 1.2× High 3.6×
Ten-year median 2.2×
Current reading's percentile 31

P/B ratio against peers

Company P/B ratio
CNC Centene Corporation compare 1.3×
CVS CVS Health Corporation compare 1.4×
CI Cigna Group compare 1.7×
ELV Elevance Health, Inc. 1.9×
MOH Molina Healthcare, Inc compare 2.3×
HUM Humana Inc. compare 2.5×
UNH UnitedHealth Group Incorporated compare 3.3×
OSCR Oscar Health, Inc. compare 4.4×
CLOV Clover Health Investments, Corp. compare 6.3×
Healthcare Plans industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ELV